Agentix Corp AGTX:OTCPK

*Data is delayed | Exchange | USD
Last | 03/21/24 EDT
0.0322UNCH (UNCH)
52 week range
0.03 - 0.13
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0322
  • 52 Week High0.13
  • 52 Week High Date08/16/23
  • 52 Week Low0.03
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap1.29M
  • Shares Out40.07M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.35
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0322
  • 52 Week High0.13
  • 52 Week High Date08/16/23
  • 52 Week Low0.03
  • 52 Week Low Date10/23/23
  • Market Cap1.29M
  • Shares Out40.07M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.35
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-1.27
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.199M
  • ROE (TTM)-745.20%
  • Revenue (TTM)-
  • Gross Margin (TTM)54.84%
  • Net Margin (TTM)-217,688.70%
  • Debt To Equity (MRQ)-3.51%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Agentix Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Agentix Corp. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic agents for the treatment of metabolic diseases like Type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Its pipeline includes AGTX-2004 and AGTX-2003. AGTX-2004 is a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus (T2DM)....
Salman Hoda
President, Chief Executive Officer, Treasurer, Company Secretary, Director
Address
32932 PACIFIC COAST HIGHWAY, #14-254
Dana Point, CA
92629
United States